Imfinzi (durvalumab) - AstraZeneca
Yervoy (ipilimumab) - Ono Pharma, BMS
CP-506 - Convert Pharma
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharma, BMS
carboplatin - Generic mfg.
Bavencio (avelumab) - EMD Serono, Pfizer
Keytruda (pembrolizumab) - Merck (MSD)
Libtayo (cemiplimab) - Regeneron
http://clinicaltrials.gov/ct2/show/NCT04954599
 
Jun 24, 2022
 
Prev Next